Consun Pharmaceutical Group Ltd 01681
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 5.85
- Day Range
- HKD 5.80–5.98
- 52-Week Range
- HKD 4.31–5.99
- Bid/Ask
- HKD 5.93 / HKD 5.98
- Market Cap
- HKD 4.85 Bil
- Volume/Avg
- 1.0 Mil / 772,159
Key Statistics
- Price/Earnings (Normalized)
- 5.33
- Price/Sales
- 1.63
- Dividend Yield (Trailing)
- 7.69%
- Dividend Yield (Forward)
- 7.69%
- Total Yield
- 7.69%
Company Profile
Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,127
- Website
- https://www.chinaconsun.com
Comparables
Valuation
|
Metric
|
01681
|
02877
|
03933
|
|---|---|---|---|
Price/Earnings (Normalized) | 5.33 | 6.56 | 5.65 |
Price/Book Value | 1.16 | 0.91 | 1.20 |
Price/Sales | 1.63 | 1.40 | 1.10 |
Price/Cash Flow | 5.12 | 6.17 | 4.64 |
Price/Earnings
01681
02877
03933
Financial Strength
|
Metric
|
01681
|
02877
|
03933
|
|---|---|---|---|
Quick Ratio | 2.60 | 2.97 | 1.60 |
Current Ratio | 2.86 | 3.35 | 2.08 |
Interest Coverage | 38.38 | 419.36 | 49.41 |
Quick Ratio
01681
02877
03933
Profitability
|
Metric
|
01681
|
02877
|
03933
|
|---|---|---|---|
Return on Assets (Normalized) | 15.68% | 10.83% | 13.68% |
Return on Equity (Normalized) | 23.45% | 13.16% | 23.45% |
Return on Invested Capital (Normalized) | 18.38% | 12.66% | 20.01% |
Return on Assets
01681
02877
03933
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Kfzgyncg | Xrjc | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Sxfwzjlxb | Tgrckpy | $69.1 Bil | |
HLN
| Haleon PLC ADR | Hrzfbzrj | Fhsr | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Wlwbcxfgd | Jmwz | $15.7 Bil | |
VTRS
| Viatris Inc | Rdxgkkksz | Dxdk | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Wkfxxpkc | Tlpw | $12.4 Bil | |
CTLT
| Catalent Inc | Ckrxjbf | Pbwstvh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Vcqrssj | Cgky | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Lmtwkdxs | Rwyb | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Mlxbhyhmr | Cxhmryy | $3.5 Bil |